In the fast-paced world of pharmaceutical development, the quality and availability of key intermediates are paramount. These specialized chemical compounds serve as the fundamental building blocks for synthesizing complex Active Pharmaceutical Ingredients (APIs). For drugs like Atogepant, a novel therapeutic agent, securing a consistent supply of high-purity intermediates is not just a logistical challenge but a scientific imperative.

At NINGBO INNO PHARMCHEM CO.,LTD., we understand that the journey from laboratory research to commercial production hinges on the integrity of every chemical component. Our focus is on providing essential pharmaceutical intermediates that meet the most stringent quality standards. One such critical compound is identified by CAS No. 1455358-12-9, a vital precursor in the synthesis of Atogepant. Its molecular formula, C18H19Cl2N3O, and molecular weight of 364.27, are precisely defined, but its true value lies in its exceptional purity, often exceeding 98%.

The development of Atogepant, a calcitonin gene-related peptide (CGRP) receptor antagonist, represents a significant advancement in migraine treatment. For researchers and manufacturers working on this groundbreaking drug, the consistent availability of intermediates like CAS 1455358-12-9 is crucial. As a dedicated manufacturer, NINGBO INNO PHARMCHEM CO.,LTD. ensures that we can buy this essential chemical reliably and in the quantities required. Our operations in China leverage advanced synthesis techniques and quality control measures to guarantee that each batch adheres to our high standards.

For procurement managers and R&D scientists, identifying a trustworthy supplier for such specialized chemicals is a strategic advantage. Knowing that a reliable manufacturer is available for intermediates like 1455358-12-9 means less risk and more confidence in project timelines and outcomes. We aim to be that partner, offering not just the product, but also the assurance of quality and a stable supply chain. This allows our clients to focus on the innovation and efficacy of their final pharmaceutical products.

If your organization is involved in the research, development, or manufacturing of Atogepant or related pharmaceuticals, understanding the price and availability of key intermediates is vital. We encourage you to inquire about our offerings for CAS 1455358-12-9. By partnering with NINGBO INNO PHARMCHEM CO.,LTD., you gain access to a high-purity pharmaceutical intermediate, backed by the expertise and reliability of a leading chemical manufacturer. This strategic sourcing decision can significantly impact the efficiency and success of your drug development pipeline.